Innovative Medicines Initiative launches new Calls for proposals

Date: 
20.03.2018

The Innovative Medicines Initiative has now launched IMI2 – Call 14. The Call has the following topics:

  • Targeted immune intervention for the management of non-response and relapse
  • Non-invasive clinical molecular imaging of immune cells
  • Development of a platform for federated and privacy-preserving machine learning in support of drug discovery
  • Centre of excellence – remote decentralised clinical trials

Deadline for submitting short proposals is 14th of June 2018.

Find our more on the IMI2 Call 14 Website